Literature DB >> 18633354

The scientific contributions of M. Judah Folkman to cancer research.

Bruce R Zetter1.   

Abstract

Dr Judah Folkman was frequently described as a highly compassionate physician who served his patients not only by performing surgery and offering them comfort and reassurance, but also by working tirelessly in the laboratory to find new approaches to the treatment of disease. His dedication to understanding the role of angiogenesis, the formation of new blood vessels, in human disease has given rise to new treatments for several diseases, including inflammatory diseases, vision-threatening diseases of the eye and, as will be emphasized in this Perspective, cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18633354     DOI: 10.1038/nrc2458

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  18 in total

Review 1.  Targeted therapies for adrenocortical carcinoma: IGF and beyond.

Authors:  Michael J Demeure; Kimberly J Bussey; Lawrence S Kirschner
Journal:  Horm Cancer       Date:  2011-12       Impact factor: 3.869

2.  Beyond antiangiogenesis: vascular modulation as an anticancer therapy-a review.

Authors:  Bryan T Oronsky; Jan J Scicinski; Tony Reid; Susan Knox
Journal:  Transl Oncol       Date:  2012-06-01       Impact factor: 4.243

Review 3.  Leukaemia 'firsts' in cancer research and treatment.

Authors:  Mel Greaves
Journal:  Nat Rev Cancer       Date:  2016-03       Impact factor: 60.716

4.  Normalizing Tumoral Vessels to Treat Cancer: An Out-of-the-Box Strategy Involving TIE2 Pathway.

Authors:  Juan Fueyo; Mohammad B Hossain; Teresa Nguyen; Candelaria Gomez-Manzano
Journal:  Transl Cancer Res       Date:  2017-03       Impact factor: 1.241

Review 5.  Normalization of the vasculature for treatment of cancer and other diseases.

Authors:  Shom Goel; Dan G Duda; Lei Xu; Lance L Munn; Yves Boucher; Dai Fukumura; Rakesh K Jain
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

6.  Transcriptional regulation of VEGFA expression in T-regulatory cells from breast cancer patients.

Authors:  Kirti Kajal; Sayantan Bose; Abir K Panda; Dwaipayan Chakraborty; Sreeparna Chakraborty; Subhadip Pati; Tania Sarkar; Subhanki Dhar; Dia Roy; Shilpi Saha; Gaurisankar Sa
Journal:  Cancer Immunol Immunother       Date:  2021-01-04       Impact factor: 6.968

Review 7.  Newly discovered angiogenesis inhibitors and their mechanisms of action.

Authors:  Ze-hong Miao; Jian-ming Feng; Jian Ding
Journal:  Acta Pharmacol Sin       Date:  2012-08-27       Impact factor: 6.150

Review 8.  Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions.

Authors:  Jessica F Yang; Amit Walia; Yu-hui Huang; Kyu-yeon Han; Mark I Rosenblatt; Dimitri T Azar; Jin-Hong Chang
Journal:  Surv Ophthalmol       Date:  2015-12-17       Impact factor: 6.048

9.  Endoglin (CD105) expression in ovarian serous carcinoma effusions is related to chemotherapy status.

Authors:  Annika J Bock; Helene Tuft Stavnes; Janne Kærn; Aasmund Berner; Anne Cathrine Staff; Ben Davidson
Journal:  Tumour Biol       Date:  2011-02-26

10.  A Proposed Paradigm Shift in Initializing Cancer Predictive Models with DCE-MRI Based PK Parameters: A Feasibility Study.

Authors:  Alexandros Roniotis; Mariam-Eleni Oraiopoulou; Eleftheria Tzamali; Eleftherios Kontopodis; Sofie Van Cauter; Vangelis Sakkalis; Kostas Marias
Journal:  Cancer Inform       Date:  2015-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.